DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang (DPM) - Total Liabilities
Latest total liabilities as of March 2024: €751.37 Billion EUR
Based on the latest financial reports, DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang (DPM) has total liabilities worth €751.37 Billion EUR as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang - Total Liabilities Trend (2017–2024)
This chart illustrates how DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang Competitors by Total Liabilities
The table below lists competitors of DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mavshack publ AB
ST:MAV
|
Sweden | Skr23.95 Million |
|
M.P.Evans Group
LSE:MPE
|
UK | GBX95.90 Million |
|
ADVANCED INF SERV(ADVANC)
STU:NVAA
|
Belgium | €312.99 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.83 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang (2017–2024)
The table below shows the annual total liabilities of DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-03-31 | €751.37 Billion | +3.22% |
| 2023-03-31 | €727.96 Billion | +14.74% |
| 2022-03-31 | €634.44 Billion | -3.87% |
| 2021-03-31 | €659.95 Billion | +6.31% |
| 2020-03-31 | €620.77 Billion | +84.44% |
| 2019-03-31 | €336.58 Billion | -5.71% |
| 2018-03-31 | €356.96 Billion | +7.10% |
| 2017-03-31 | €333.29 Billion | -- |